Elmeri Matias Jokinen (Elmeri M Jokinen)

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 6

Top Topics

Atopic Dermatitis

Molecular Dynamics Simulations

Protein Protein

Top Venues

Molecules (Basel, Switzerland)

Chemical biology & drug design

This page only lists publications with an associated author ORCID identifier.

Publications

Elmeri Matias Jokinen, Miika Niemeläinen, Sami T Kurkinen, Jukka V Lehtonen, Sakari T Lätti, Pekka A Postila, Olli Taneli Pentikäinen, Sanna P Niinivehmas
Virtual Screening Strategy to Identify Retinoic Acid-Related Orphan Receptor γt Modulators. Molecules (Basel, Switzerland) 28 (8) (2023)
Elmeri Matias Jokinen, Miika Niemeläinen, Sami T Kurkinen, Jukka V Lehtonen, Sakari T Lätti, Pekka A Postila, Olli Taneli Pentikäinen, Sanna P Niinivehmas
Virtual Screening Strategy to Identify Retinoic Acid-Related Orphan Receptor γt Modulators. Molecules (Basel, Switzerland) 28 (8) (2023)
Elmeri Matias Jokinen, Miika Niemeläinen, Sami T Kurkinen, Jukka V Lehtonen, Sakari T Lätti, Pekka A Postila, Olli Taneli Pentikäinen, Sanna P Niinivehmas
Virtual Screening Strategy to Identify Retinoic Acid-Related Orphan Receptor γt Modulators. Molecules (Basel, Switzerland) 28 (8) (2023)
Elmeri Matias Jokinen, Miika Niemeläinen, Sami T Kurkinen, Jukka V Lehtonen, Sakari T Lätti, Pekka A Postila, Olli Taneli Pentikäinen, Sanna P Niinivehmas
Virtual Screening Strategy to Identify Retinoic Acid-Related Orphan Receptor γt Modulators. Molecules (Basel, Switzerland) 28 (8) (2023)
Risto Olavi Juvonen, Elmeri Matias Jokinen, Adeel Javaid, Marko Lehtonen, Hannu Raunio, Olli Taneli Pentikäinen
Inhibition of human CYP1 enzymes by a classical inhibitor α-naphthoflavone and a novel inhibitor N-(3, 5-dichlorophenyl)cyclopropanecarboxamide: An in vitro and in silico study. Chemical biology & drug design 95 (5) (2020)
Elmeri Matias Jokinen, Pekka A Postila, Mira Ahinko, Sanna Niinivehmas, Olli Taneli Pentikäinen
Fragment- and negative image-based screening of phosphodiesterase 10A inhibitors. Chemical biology & drug design 94 (4) (2019)